HomeToday’s HighlightsThe Amgen/Novartis story. A Little Curiosity About Alder Biopharmaceuticals. The Amgen/Novartis story. A Little Curiosity About Alder Biopharmaceuticals. Today’s Highlights April 8, 2019 The Amgen/Novartis Story In May 2018 Amgen (AMGN) & Novartis (This content is for paid subscribers. Please click here to subscribe or here to log in. Today’s Highlights Alder BioPharmaceuticals (ALDR), Amgen (AMGN), Novartis (NVS) April 8, 2019 Tweet Pin It Other Articles Vertex Pharmaceuticals Announces Positive Week 36 Interim Analysis Results for Primary and All Secondary Endpoints in the RAINIER Phase 3 Trial of Povetacicept in Adults with IgA Nephropathy March 9, 2026 0 Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE Phase 3 Clinical Trial in ATTR-CM March 2, 2026 0 Intellia Therapeutics Announces Q4 and Full-Year 2025 Financial Results and Business Updates February 26, 2026 0 Novo Nordisk Announces Significant Reduction in US List Price for Wegovy®, Ozempic® and Rybelsus®, Building on Continued Efforts to Expand Access February 24, 2026 0